Institute of Immunology
Lifan Xu has not added Biography.
If you are Lifan Xu and would like to personalize this page please email our Author Liaison for assistance.
[Epigenetics in cancer stem cells].
Yi chuan = Hereditas Sep, 2013 | Pubmed ID: 24400477
The transcription factor TCF-1 initiates the differentiation of T(FH) cells during acute viral infection.
Nature immunology Sep, 2015 | Pubmed ID: 26214740
Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection.
Nature 08, 2016 | Pubmed ID: 27501245
mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses.
Journal of virology 02, 2017 | Pubmed ID: 27974559
Mammalian target of rapamycin complex 1 signalling is essential for germinal centre reaction.
Immunology 10, 2017 | Pubmed ID: 28557002
The Kinase mTORC1 Promotes the Generation and Suppressive Function of Follicular Regulatory T Cells.
Immunity 09, 2017 | Pubmed ID: 28930662
Flow Cytometry Analysis of mTOR Signaling in Antigen-Specific B Cells.
Methods in molecular biology (Clifton, N.J.) , 2018 | Pubmed ID: 29388102
The Transcription Factor TCF1 Preserves the Effector Function of Exhausted CD8 T Cells During Chronic Viral Infection.
Frontiers in immunology , 2019 | Pubmed ID: 30814995
Molecular Basis of the Differentiation and Function of Virus Specific Follicular Helper CD4 T Cells.
Frontiers in immunology , 2019 | Pubmed ID: 30828337
The histone methyltransferase EZH2 primes the early differentiation of follicular helper T cells during acute viral infection.
Cellular & molecular immunology Mar, 2019 | Pubmed ID: 30842630
The Transcription Factor T-Bet Is Required for Optimal Type I Follicular Helper T Cell Maintenance During Acute Viral Infection.
Frontiers in immunology , 2019 | Pubmed ID: 30984183
Sclerostin domain-containing protein 1 is dispensable for the differentiation of follicular helper and follicular regulatory T cells during acute viral infection.
American journal of translational research , 2019 | Pubmed ID: 31312383
T cell immune response within B-cell follicles.
Advances in immunology , 2019 | Pubmed ID: 31699216
Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor.
Cellular & molecular immunology 06, 2020 | Pubmed ID: 32313207
Bcl6 Preserves the Suppressive Function of Regulatory T Cells During Tumorigenesis.
Frontiers in immunology , 2020 | Pubmed ID: 32477338
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19.
Signal transduction and targeted therapy 09, 2020 | Pubmed ID: 32879307
METTL3-dependent mA modification programs T follicular helper cell differentiation.
Nature communications 02, 2021 | Pubmed ID: 33637761
Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody.
Frontiers in immunology , 2021 | Pubmed ID: 34630430
The kinase complex mTORC2 promotes the longevity of virus-specific memory CD4 T cells by preventing ferroptosis.
Nature immunology Feb, 2022 | Pubmed ID: 34949833
Differential expression of inhibitory receptor NKG2A distinguishes disease-specific exhausted CD8 T cells.
MedComm Mar, 2022 | Pubmed ID: 35281793
A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD.
Signal transduction and targeted therapy Apr, 2022 | Pubmed ID: 35383141
A novel strategy to investigate the factors regulating the Treg to Tfr transition during acute viral infection.
Journal of immunological methods Jun, 2022 | Pubmed ID: 35398062
CD4 T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy.
Journal for immunotherapy of cancer May, 2022 | Pubmed ID: 35580929
Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical Trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Feb, 2023 | Pubmed ID: 35666466
Tumor-Specific CD4 T Cells Restrain Established Metastatic Melanoma by Developing Into Cytotoxic CD4 T Cells.
Frontiers in immunology , 2022 | Pubmed ID: 35784297
The primordial differentiation of tumor-specific memory CD8 T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodes.
Cell Oct, 2022 | Pubmed ID: 36208623
Tumor-specific memory CD8 T cells are strictly resident in draining lymph nodes during tumorigenesis.
Cellular & molecular immunology Apr, 2023 | Pubmed ID: 36859455
Author Correction: Tumor-specific memory CD8 T cells are strictly resident in draining lymph nodes during tumorigenesis.
Cellular & molecular immunology Jul, 2023 | Pubmed ID: 37225839
PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness.
Vaccine Jul, 2023 | Pubmed ID: 37400286
Lisha Wang1,
Zhiming Wang1,
Junyi Guo2,
Huayu Lin1,
Shuqiong Wen2,
Qiao Liu1,
Yiding Li3,
Qing Wu1,
Leiqiong Gao1,
Xiangyu Chen1,
Luoyingzi Xie1,
Qin Tian1,
Jianfang Tang1,
Zhirong Li1,
Li Hu1,
Juan Wang4,
Lifan Xu1,
Qizhao Huang5,
Lilin Ye1
1Institute of Immunology, Third Military Medical University,
2Guanghua School of Stomatology, Guangdong Provincial Key Laboratory of Stomatology, Stomatological Hospital, Sun Yat-Sen University,
3Shigatse Branch, Xinqiao Hospital, Third Military Medical University,
4Department of Emergency Medicine, Southwest Hospital, Third Military Medical University,
5Cancer Center, The General Hospital of Western Theater Command
Yan Zhang*,1,
Xingxing Su*,2,
Lisha Wang2,
Zhengliang Yue2,
Qiao Liu3,
Ling Ran2,
Shun Lei2,
Jianjun Hu2,
Lifan Xu2,
Lilin Ye2,
Ping Ji4,
Guimei Li1,
Qizhao Huang5,
Shuqiong Wen4
1College of Veterinary Medicine, Qingdao Agricultural University,
2Institute of Immunology, Third Military Medical University,
3Institute of Cancer, Xinqiao Hospital, Third Military Medical University,
4, Stomatological Hospital of Chongqing Medical University,
5Institute of life science, Chongqing Medical University
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados